GlobalSilk Fibroin (SF) Competitive Landscape Professional Research Report 2026
Market Overview According to DIResearch's in-depth investigation and research, the global Silk Fibroin (SF) market size will reach 130.91 Million USD in 2026 and is projected to reach 198.67 Mi... もっと見る
出版社
出版年月
2026年6月17日
電子版価格
納期
お問合わせください
ページ数
171
言語
英語
日本語のページはAI翻訳を利用し作成しています。
SummaryMarket OverviewAccording to DIResearch's in-depth investigation and research, the global Silk Fibroin (SF) market size will reach 130.91 Million USD in 2026 and is projected to reach 198.67 Million USD by 2033, with a CAGR of 6.14% (2026-2033). Notably, the China Silk Fibroin (SF) market has changed rapidly in the past few years. By 2026, China's market size is expected to be Million USD, representing approximately % of the global market share. Research Summary Silk fibroin (SF) is a natural fibrous protein primarily derived from silkworm cocoons, accounting for 70–80% of the total silk weight. Composed mainly of amino acids such as glycine, alanine, and serine, it features a unique combination of β-sheet structures and random coil regions, which confer high strength, excellent toughness, and flexible processability. In addition to its outstanding mechanical properties, silk fibroin exhibits good biocompatibility and biodegradability, gradually breaking down into amino acids in the body. It is widely used in tissue engineering scaffolds, biodegradable sutures, drug delivery systems, as well as high-end textiles and functional materials. Its natural renewability, versatile processing potential, and compatibility with the human body make it highly valuable in biomedical and material science applications. The major global manufacturers of Silk Fibroin (SF) include Worldway Co., Ltd, Croda International, AMSilk GmbH, Zhejiang Cathaya International Co., Ltd, Zhejiang Xingyue Biotechnology Co.,Ltd, Suzhou Soho Biomaterials Technology Co.,Ltd, Nanjing Siyuan Medical Technology Co., Ltd., Favorsun, Kelisema Srl, CellaMatrix, Cocoon Biotech, Sollice Biotech, Caresilk, Strong Biologics, Shanghai Siyan Biotechnology Co., Ltd, Fibroheal Woundcare, Bugamed Biotechnology Inc, Nagasuna mayu inc, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue. This report studies the market size, price trends and future development prospects of Silk Fibroin (SF). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Silk Fibroin (SF) market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033. The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Silk Fibroin (SF) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Silk Fibroin (SF) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy. The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database. Global Key Manufacturers of Silk Fibroin (SF) Include: Worldway Co., Ltd Croda International AMSilk GmbH Zhejiang Cathaya International Co., Ltd Zhejiang Xingyue Biotechnology Co.,Ltd Suzhou Soho Biomaterials Technology Co.,Ltd Nanjing Siyuan Medical Technology Co., Ltd. Favorsun Kelisema Srl CellaMatrix Cocoon Biotech Sollice Biotech Caresilk Strong Biologics Shanghai Siyan Biotechnology Co., Ltd Fibroheal Woundcare Bugamed Biotechnology Inc Nagasuna mayu inc Silk Fibroin (SF) Product Segment Include: Silk Fibroin (30–300 kDa) Silk Peptides (500–30,000 Da) Silk Amino Acids (75–500 Da) Silk Fibroin (SF) Product Application Include: Personal Care Biomedicine Others Chapter Scope Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends Chapter 2: Global Silk Fibroin (SF) Industry PESTEL Analysis Chapter 3: Global Silk Fibroin (SF) Industry Porter’s Five Forces Analysis Chapter 4: Global Silk Fibroin (SF) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis Chapter 5: Global Silk Fibroin (SF) Market Size and Forecast by Type and Application Analysis Chapter 6: North America Silk Fibroin (SF) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 7: Europe Silk Fibroin (SF) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 8: China Silk Fibroin (SF) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 9: APAC (Excl. China) Silk Fibroin (SF) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 10: Latin America Silk Fibroin (SF) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 11: Middle East and Africa Silk Fibroin (SF) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 12: Global Silk Fibroin (SF) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration) Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin) Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers Chapter 15: Research Findings and Conclusion Chapter 16: Methodology and Data Sources Table of ContentsTable of Contents1 Silk Fibroin (SF) Market Overview 1.1 Product Definition and Statistical Scope 1.2 Silk Fibroin (SF) Product by Type 1.2.1 Silk Fibroin (30–300 kDa) 1.2.2 Silk Peptides (500–30,000 Da) 1.2.3 Silk Amino Acids (75–500 Da) 1.3 Silk Fibroin (SF) Product by Application 1.3.1 Personal Care 1.3.2 Biomedicine 1.3.3 Others 1.4 Global Silk Fibroin (SF) Market Revenue and Sales Analysis 1.4.1 Global Silk Fibroin (SF) Revenue Market Size Analysis (2021-2033) 1.4.2 Global Silk Fibroin (SF) Sales Market Size Analysis (2021-2033) 1.4.3 Global Silk Fibroin (SF) Market Sales Price Trend Analysis (2021-2033) 1.5 Silk Fibroin (SF) Industry Trends and Innovation 1.5.1 Silk Fibroin (SF) Industry Trends and Innovation 1.5.2 Silk Fibroin (SF) Market Drivers and Challenges 2 Silk Fibroin (SF) Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Silk Fibroin (SF) Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Silk Fibroin (SF) Market Analysis by Regions 4.1 Silk Fibroin (SF) Overall Market: 2025 VS 2026 VS 2033 4.2 Global Silk Fibroin (SF) Revenue and Forecast Analysis (2021-2033) 4.2.1 Global Silk Fibroin (SF) Revenue and Market Share by Region (2021-2026) 4.2.2 Global Silk Fibroin (SF) Revenue and Market Share Forecast by Region (2027-2033) 4.3 Global Silk Fibroin (SF) Sales and Forecast Analysis (2021-2033) 4.3.1 Global Silk Fibroin (SF) Sales and Market Share by Region (2021-2026) 4.3.2 Global Silk Fibroin (SF) Sales and Market Share Forecast by Region (2027-2033) 4.4 Global Silk Fibroin (SF) Sales Price Trend Analysis (2021-2033) 5 Global Silk Fibroin (SF) Market Size by Type and Application 5.1 Global Silk Fibroin (SF) Market Size by Type 5.1.1 Global Silk Fibroin (SF) Revenue and Forecast Analysis by Type (2021-2033) 5.1.2 Global Silk Fibroin (SF) Sales and Forecast Analysis by Type (2021-2033) 5.2 Global Silk Fibroin (SF) Market Size by Application 5.2.1 Global Silk Fibroin (SF) Revenue and Forecast Analysis by Application (2021-2033) 5.2.2 Global Silk Fibroin (SF) Sales and Forecast Analysis by Application (2021-2033) 6 North America 6.1 North America Silk Fibroin (SF) Market Size and Growth Rate Analysis (2021-2033) 6.2 North America Key Manufacturers Analysis 6.3 North America Silk Fibroin (SF) Market Size by Type 6.3.1 North America Silk Fibroin (SF) Sales by Type (2021-2033) 6.3.2 North America Silk Fibroin (SF) Revenue by Type (2021-2033) 6.4 North America Silk Fibroin (SF) Market Size by Application 6.4.1 North America Silk Fibroin (SF) Sales by Application (2021-2033) 6.4.2 North America Silk Fibroin (SF) Revenue by Application (2021-2033) 6.5 North America Silk Fibroin (SF) Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Silk Fibroin (SF) Market Size and Growth Rate Analysis (2021-2033) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Silk Fibroin (SF) Market Size by Type 7.3.1 Europe Silk Fibroin (SF) Sales by Type (2021-2033) 7.3.2 Europe Silk Fibroin (SF) Revenue by Type (2021-2033) 7.4 Europe Silk Fibroin (SF) Market Size by Application 7.4.1 Europe Silk Fibroin (SF) Sales by Application (2021-2033) 7.4.2 Europe Silk Fibroin (SF) Revenue by Application (2021-2033) 7.5 Europe Silk Fibroin (SF) Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Silk Fibroin (SF) Market Size and Growth Rate Analysis (2021-2033) 8.2 China Key Manufacturers Analysis 8.3 China Silk Fibroin (SF) Market Size by Type 8.3.1 China Silk Fibroin (SF) Sales by Type (2021-2033) 8.3.2 China Silk Fibroin (SF) Revenue by Type (2021-2033) 8.4 China Silk Fibroin (SF) Market Size by Application 8.4.1 China Silk Fibroin (SF) Sales by Application (2021-2033) 8.4.2 China Silk Fibroin (SF) Revenue by Application (2021-2033) 9 APAC (excl. China) 9.1 APAC (excl. China) Silk Fibroin (SF) Market Size and Growth Rate Analysis (2021-2033) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Silk Fibroin (SF) Market Size by Type 9.3.1 APAC (excl. China) Silk Fibroin (SF) Sales by Type (2021-2033) 9.3.2 APAC (excl. China) Silk Fibroin (SF) Revenue by Type (2021-2033) 9.4 APAC (excl. China) Silk Fibroin (SF) Market Size by Application 9.4.1 APAC (excl. China) Silk Fibroin (SF) Sales by Application (2021-2033) 9.4.2 APAC (excl. China) Silk Fibroin (SF) Revenue by Application (2021-2033) 9.5 APAC (excl. China) Silk Fibroin (SF) Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Southeast Asia 10 Latin America 10.1 Latin America Silk Fibroin (SF) Market Size and Growth Rate Analysis (2021-2033) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Silk Fibroin (SF) Market Size by Type 10.3.1 Latin America Silk Fibroin (SF) Sales by Type (2021-2033) 10.3.2 Latin America Silk Fibroin (SF) Revenue by Type (2021-2033) 10.4 Latin America Silk Fibroin (SF) Market Size by Application 10.4.1 Latin America Silk Fibroin (SF) Sales by Application (2021-2033) 10.4.2 Latin America Silk Fibroin (SF) Revenue by Application (2021-2033) 10.5 Latin America Silk Fibroin (SF) Market Size by Country 10.6 Latin America Silk Fibroin (SF) Market Size by Country 10.6.1 Mexico 10.6.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Silk Fibroin (SF) Market Size and Growth Rate Analysis (2021-2033) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Silk Fibroin (SF) Market Size by Type 11.3.1 Middle East & Africa Silk Fibroin (SF) Sales by Type (2021-2033) 11.3.2 Middle East & Africa Silk Fibroin (SF) Revenue by Type (2021-2033) 11.4 Middle East & Africa Silk Fibroin (SF) Market Size by Application 11.4.1 Middle East & Africa Silk Fibroin (SF) Sales by Application (2021-2033) 11.4.2 Middle East & Africa Silk Fibroin (SF) Revenue by Application (2021-2033) 11.5 Middle East Silk Fibroin (SF) Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Silk Fibroin (SF) Market Sales, Revenue and Price by Key Manufacturers (2021-2026) 12.1.1 Global Silk Fibroin (SF) Market Sales by Key Manufacturers (2021-2026) 12.1.2 Global Silk Fibroin (SF) Market Revenue by Key Manufacturers (2021-2026) 12.1.3 Global Silk Fibroin (SF) Average Sales Price by Manufacturers (2021-2026) 12.2 Silk Fibroin (SF) Competitive Landscape Analysis and Market Dynamic 12.2.1 Silk Fibroin (SF) Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Worldway Co., Ltd 13.1.1 Worldway Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Worldway Co., Ltd Silk Fibroin (SF) Product Portfolio 13.1.3 Worldway Co., Ltd Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.2 Croda International 13.2.1 Croda International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Croda International Silk Fibroin (SF) Product Portfolio 13.2.3 Croda International Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.3 AMSilk GmbH 13.3.1 AMSilk GmbH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 AMSilk GmbH Silk Fibroin (SF) Product Portfolio 13.3.3 AMSilk GmbH Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.4 Zhejiang Cathaya International Co., Ltd 13.4.1 Zhejiang Cathaya International Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Zhejiang Cathaya International Co., Ltd Silk Fibroin (SF) Product Portfolio 13.4.3 Zhejiang Cathaya International Co., Ltd Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.5 Zhejiang Xingyue Biotechnology Co.,Ltd 13.5.1 Zhejiang Xingyue Biotechnology Co.,Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Zhejiang Xingyue Biotechnology Co.,Ltd Silk Fibroin (SF) Product Portfolio 13.5.3 Zhejiang Xingyue Biotechnology Co.,Ltd Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.6 Suzhou Soho Biomaterials Technology Co.,Ltd 13.6.1 Suzhou Soho Biomaterials Technology Co.,Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Suzhou Soho Biomaterials Technology Co.,Ltd Silk Fibroin (SF) Product Portfolio 13.6.3 Suzhou Soho Biomaterials Technology Co.,Ltd Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.7 Nanjing Siyuan Medical Technology Co., Ltd. 13.7.1 Nanjing Siyuan Medical Technology Co., Ltd. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Nanjing Siyuan Medical Technology Co., Ltd. Silk Fibroin (SF) Product Portfolio 13.7.3 Nanjing Siyuan Medical Technology Co., Ltd. Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.8 Favorsun 13.8.1 Favorsun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Favorsun Silk Fibroin (SF) Product Portfolio 13.8.3 Favorsun Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.9 Kelisema Srl 13.9.1 Kelisema Srl Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Kelisema Srl Silk Fibroin (SF) Product Portfolio 13.9.3 Kelisema Srl Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.10 CellaMatrix 13.10.1 CellaMatrix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 CellaMatrix Silk Fibroin (SF) Product Portfolio 13.10.3 CellaMatrix Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.11 Cocoon Biotech 13.11.1 Cocoon Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Cocoon Biotech Silk Fibroin (SF) Product Portfolio 13.11.3 Cocoon Biotech Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.12 Sollice Biotech 13.12.1 Sollice Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Sollice Biotech Silk Fibroin (SF) Product Portfolio 13.12.3 Sollice Biotech Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.13 Caresilk 13.13.1 Caresilk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Caresilk Silk Fibroin (SF) Product Portfolio 13.13.3 Caresilk Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.14 Strong Biologics 13.14.1 Strong Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Strong Biologics Silk Fibroin (SF) Product Portfolio 13.14.3 Strong Biologics Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.15 Shanghai Siyan Biotechnology Co., Ltd 13.15.1 Shanghai Siyan Biotechnology Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Shanghai Siyan Biotechnology Co., Ltd Silk Fibroin (SF) Product Portfolio 13.15.3 Shanghai Siyan Biotechnology Co., Ltd Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.16 Fibroheal Woundcare 13.16.1 Fibroheal Woundcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Fibroheal Woundcare Silk Fibroin (SF) Product Portfolio 13.16.3 Fibroheal Woundcare Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.17 Bugamed Biotechnology Inc 13.17.1 Bugamed Biotechnology Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.17.2 Bugamed Biotechnology Inc Silk Fibroin (SF) Product Portfolio 13.17.3 Bugamed Biotechnology Inc Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 13.18 Nagasuna mayu inc 13.18.1 Nagasuna mayu inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.18.2 Nagasuna mayu inc Silk Fibroin (SF) Product Portfolio 13.18.3 Nagasuna mayu inc Silk Fibroin (SF) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026) 14 Industry Chain Analysis 14.1 Silk Fibroin (SF) Industry Chain Analysis 14.2 Silk Fibroin (SF) Industry Raw Material and Suppliers Analysis 14.2.1 Silk Fibroin (SF) Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Silk Fibroin (SF) Typical Downstream Customers 14.4 Silk Fibroin (SF) Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
DIResearch社の 医薬品・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD(landscape)の最新刊レポート
よくあるご質問DIResearch社はどのような調査会社ですか?Deep Insight Research (DIResearch)は50,000以上のマーケットをモニターする調査会社で、最新・コストパフォーマンスを重視したレポートを出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|